SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CMPX

Compass Therapeutics, Inc. (NASDAQ:CMPX)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.69+$0.01 (+1.43%)
 
Market cap
$124M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 5, 2021
Market Cap$123.94M-86.1%
Revenue (ttm)$0
Net Income-$86.36M-31.2%
EPS-$0.46+1.1%
Shares Out180.09M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,823,573
Open$0.68
Previous Close$0.68
Day's Range$0.64 - $0.73
52-Week Range$0.57 - $6.88
Beta0.91
AnalystsBuy
Price Target$4.67(+578.58%)
Earnings DateMar 4, 2027

About CMPX

Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating antibody-based medicines designed to address a variety of human health conditions. Among its leading clinical-stage programs are CTX-009, an experimental bispecific antibody engineered to inhibit the Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, both of which are crucial for the growth of new blood vessels and tumor vascularization. Another significant compound is CTX-471, an IgG4 monoclonal antibody that functions as an activator of CD137. Furthermore, their developmental pipeline features CTX-8371, a bispecific inhibitor that targets both PD-1 and PD-L1. The company was established in 2014 and operates from its headquarters in Boston, Massachusetts.

Address
80 Guest Street, Boston, MA, 02135, US
Market Cap
124 million
Employees
39
Industrial Classification
Biotechnology

Compass Therapeutics, Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
70th Percentile Overall Score
CMPX InsiderScore:80 / 99

Compass Therapeutics, Inc. scored higher than 70% of companies evaluated by InsiderBuying, and ranked 27th out of 110 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Compass Therapeutics, Inc. bought $27.1K of stock across 3 purchases in the last 90 days, the largest of them $18.4K.

Stake Increase

The average purchase added about 3% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$27.15K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
4 Buy1 Hold0 SellAvg target $6.50 (+844.5%)

5 firms rating CMPX in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From CMPX’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
+1.43%
5 Days
-10.34%
1 Month
-14.14%
6 Months
-66.75%
1 Year
-86.10%

$CMPX stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CMPX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CMPX's directors and management

Net Shares Purchased by Insiders−30k−15k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CMPX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New CMPX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CMPX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CMPX

XBIState Street SPDR S&P Biotech ETF$3.34M
VTIVanguard Morningstar Total Stock Market ETF$2.60M
IWMiShares Russell 2000 ETF$2.37M
VXFVanguard Extended Market ETF$1.31M
FESMFidelity Enhanced Small Cap ETF$1.17M
IWNiShares Russell 2000 Value ETF$822.17K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CMPX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
58.29
Analyst Ratings
40% of score
85
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
3
Sells
0
Buy Value
$27.15K
Distinct Buyers
1

Insider Score Trend Over Time

+34.7 since Sep 26
0255075100Sep 26 — Insider Score 44.9Sep 27 — Insider Score 45.0Sep 28 — Insider Score 44.9Sep 29 — Insider Score 44.3Sep 30 — Insider Score 43.9Oct 1 — Insider Score 43.1Oct 2 — Insider Score 34.0Oct 3 — Insider Score 42.8Oct 4 — Insider Score 54.8Oct 5 — Insider Score 54.8Oct 6 — Insider Score 54.3Oct 7 — Insider Score 54.2Oct 8 — Insider Score 54.0Oct 9 — Insider Score 53.9Oct 10 — Insider Score 53.5Oct 11 — Insider Score 54.1Oct 12 — Insider Score 54.2Oct 13 — Insider Score 54.0Oct 14 — Insider Score 53.6Oct 15 — Insider Score 53.4Oct 16 — Insider Score 53.3Oct 17 — Insider Score 53.2Oct 18 — Insider Score 53.4Oct 19 — Insider Score 53.5Oct 20 — Insider Score 53.4Oct 21 — Insider Score 53.3Oct 22 — Insider Score 53.1Oct 23 — Insider Score 53.0Oct 24 — Insider Score 53.0Oct 25 — Insider Score 52.8Oct 26 — Insider Score 52.3Oct 27 — Insider Score 52.3Oct 28 — Insider Score 52.1Oct 29 — Insider Score 51.4Oct 30 — Insider Score 50.3Oct 31 — Insider Score 50.0Nov 1 — Insider Score 50.0Nov 2 — Insider Score 50.0Nov 3 — Insider Score 48.9Nov 4 — Insider Score 48.0Nov 5 — Insider Score 47.3Nov 6 — Insider Score 46.3Nov 7 — Insider Score 45.7Nov 8 — Insider Score 46.4Nov 9 — Insider Score 46.5Nov 10 — Insider Score 44.7Nov 11 — Insider Score 43.9Nov 12 — Insider Score 43.5Nov 13 — Insider Score 41.9Nov 14 — Insider Score 40.9Nov 15 — Insider Score 41.3Nov 16 — Insider Score 40.6Nov 17 — Insider Score 38.8Nov 18 — Insider Score 83.0Nov 19 — Insider Score 81.8Nov 20 — Insider Score 81.3Nov 21 — Insider Score 79.5Nov 22 — Insider Score 79.5Sep 26Oct 24Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BBCVirtus Biotech Clinical Trials ETF0.30%
SBIOALPS Medical Breakthroughs ETF0.10%
XBIState Street SPDR S&P Biotech ETF0.04%
FESMFidelity Enhanced Small Cap ETF0.02%
PWSPacer WealthShield ETF0.01%
LABUDirexion Daily S&P Biotech Bull 3X Shares0.01%
FSEVFidelity Enhanced Small Cap Value ETF0.00%
VHTVanguard Health Care ETF0.00%

Weight is the stock’s share of each fund’s holdings.